This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: University of Miami. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Bonnie Beth Blomberg
Introduction
Bonnie Beth Blomberg is a notable inventor based in Coral Gables, Florida. She has made significant contributions to the field of vaccine development, particularly through her innovative work on nanoparticle-based vaccines. Her research focuses on effective delivery methods for antigens, which are crucial for vaccination and antibody production.
Latest Patents
Bonnie Beth Blomberg holds one patent titled "Vaccine compositions and methods of use thereof." This patent describes nanoparticle-based vaccines, compositions, kits, and methods that facilitate the effective delivery of one or more antigens in vivo. The technology aims to enhance the immune response against infectious pathogens or cancer by utilizing various delivery mechanisms, including the use of charged dendrimers. The compositions and methods outlined in her patent have both prophylactic and therapeutic applications, making them valuable in the fight against diseases.
Career Highlights
Blomberg is affiliated with the University of Miami, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize vaccine delivery systems and improve patient outcomes.
Collaborations
She has collaborated with notable colleagues, including Pirouz Daftarian and Paolo Serafini, to advance her research initiatives. Their combined expertise contributes to the innovative approaches being developed in the field of immunology.
Conclusion
Bonnie Beth Blomberg's contributions to vaccine technology exemplify the impact of innovative research in healthcare. Her work not only enhances our understanding of immune responses but also paves the way for more effective vaccination strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
